Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke 39:850-856, Diringer,M.N.,et al, 2008
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
JAMA 295:293-298, OConnell,K.A.,et al, 2006
Unexpected Posthemorrhagic Hydrocephalus in Patients Treated with rFVIIa
Neurol 67:1096, Subramaniam,S.,et al, 2006
Myocardial Injury in patients with Intracerebral Hemorrhage Treated with Recombinant Factor VIIa
Neurol 67:1053-1055, Sugg,R.M.,et al, 2006
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005